tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Silvan Tuerkcan, 157 are a BUY (97.52%), 4 are a HOLD (2.48%).
Analyst Silvan Tuerkcan, currently employed at JMP, carries an average stock price target met ratio of 40.58% that have a potential upside of 42.21% achieved within 107 days.
Silvan Tuerkcan’s has documented 313 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JSPR, Jasper Therapeutics at 08-Jul-2025.
Analyst best performing recommendations are on LOGC (LOGICBIO THERAPEUTICS).
The best stock recommendation documented was for MRTX (MIRATI THER) at 9/28/2023. The price target of $58 was fulfilled within 7 days with a profit of $12.65 (27.89%) receiving and performance score of 39.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$40
$-4.86 (-10.83%)
$29
4 days ago
(09-Jul-2025)
6/8 (75%)
$-5.17 (-11.45%)
961
Buy
$50
$5.14 (11.46%)
$40
6 days ago
(07-Jul-2025)
9/11 (81.82%)
$6.49 (14.92%)
148
Buy
$53
$8.14 (18.15%)
$47
14 days ago
(29-Jun-2025)
8/10 (80%)
$8.92 (20.24%)
127
Buy
$55
$10.14 (22.60%)
$43
21 days ago
(22-Jun-2025)
11/12 (91.67%)
$11.63 (26.82%)
822
Buy
$50
$5.14 (11.46%)
$41
21 days ago
(22-Jun-2025)
21/22 (95.45%)
$6.63 (15.29%)
450
Which stock is Silvan Tuerkcan is most bullish on?
Which stock is Silvan Tuerkcan is most reserved on?
What Year was the first public recommendation made by Silvan Tuerkcan?
